What is the survival rate for chronic myelomonocytic leukemia in a 69-year-old patient?

No direct evidence for specific survival rates in a 69-year-old with CMML; general survival ranges from 10-16 months, with treatment options like Azacitidine potentially extending this.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24344186
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What is the survival rate for chronic myelomonocytic leukemia in a 69-year-old patient?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Acute Myeloid Leukemia Research
article

What is the survival rate for chronic myelomonocytic leukemia in a 69-year-old patient?

Tripdatabase
article en

Abstract

No direct evidence for specific survival rates in a 69-year-old with CMML; general survival ranges from 10-16 months, with treatment options like Azacitidine potentially extending this.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon